Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) Return on Equity (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Return on Equity for 12 consecutive years, with 1.84% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity fell 170.0% year-over-year to 1.84%, compared with a TTM value of 1.84% through Sep 2025, down 170.0%, and an annual FY2024 reading of 0.24%, down 13.0% over the prior year.
  • Return on Equity was 1.84% for Q3 2025 at Sanara MedTech, down from 0.19% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.1% in Q4 2023 and bottomed at 1.84% in Q3 2025.
  • Average Return on Equity over 5 years is 0.28%, with a median of 0.2% recorded in 2023.
  • The sharpest move saw Return on Equity soared 87bps in 2021, then tumbled -170bps in 2025.
  • Year by year, Return on Equity stood at 0.24% in 2021, then rose by 8bps to 0.22% in 2022, then surged by 54bps to 0.1% in 2023, then plummeted by -79bps to 0.18% in 2024, then crashed by -925bps to 1.84% in 2025.
  • Business Quant data shows Return on Equity for SMTI at 1.84% in Q3 2025, 0.19% in Q2 2025, and 0.23% in Q1 2025.